MedTrace Logo

Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients

NCT00461942 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2011-08-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease Patients without taking any antiparkinsonism drug

Conditions

Interventions

DRUG

Green Tea Polyphenols (EGCG/ECG)

Sponsors & Collaborators

  • Ministry of Health, China

    collaborator OTHER_GOV

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Piu Chan, MD, PhD · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2009-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00461942 on ClinicalTrials.gov